Time to MACE and its individual components (CV death, nonfatal MI, nonfatal stroke), hospitalization for unstable angina or heart failure, and revascularization (coronary and peripheral) were analyzed for all subgroups
This active comparator design was selected to ensure that all patients had similar motivations for weight management and shared comparable baseline characteristics, thus allowing for a more accurate comparison of outcomes
In TRIUMPH-2, discontinuation due to adverse events ranged from 3.8% to 11.6% across retatrutide dose groups compared with 4.9% for placebo
While awaiting FDA approval, understanding side effects and safety is crucial for Carrollton, Georgia, residents contemplating Retatrutide weight loss
To the best of our knowledge, the assays where DTNB, GSSG, Trx, and NADPH (at saturating concentrations) are utilized as substrates are the only assays used to measure activity of TGR and related enzymes, including human TrxR and GR 59